Lipid metabolism offers anticancer treatment by regulating ferroptosis

Article metrics

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1

References

  1. 1.

    Tesfay L, Paul BT, Konstorum A, Deng Z, Cox AO, Lee J, et al. Steroyl-CoA Desaturase 1 (SCD1) protects ovarian cancer cells from ferroptotic cell death. Cancer Res. 2019. https://doi.org/10.1158/0008-5472.CAN-19-0369. [Epub ahead of print]

  2. 2.

    Pisanu ME, Noto A, De Vitis C, Morrone S, Scognamiglio G, Botti G, et al. Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells. Cancer Lett. 2017;406:93–104. https://doi.org/10.1016/j.canlet.2017.07.027

  3. 3.

    Noto A, De Vitis C, Pisanu ME, Roscilli G, Ricci G, Catizone A, et al. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ. Oncogene. 2017;36:4671–2. https://doi.org/10.1038/onc.2017.212

  4. 4.

    Tracz-Gaszewska Z, Dobrzyn P. Stearoyl-CoA desaturase 1 as a therapeutic target for the treatment of cancer. Cancers (Basel). 2019;11:E948. https://doi.org/10.3390/cancers11070948

  5. 5.

    Dixon SJ, Stockwell BR. The hallmarks of ferroptosis. Annu Rev Cancer Biol. 2019;3:35–54.

  6. 6.

    Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting ferroptosis to iron out cancer. Cancer Cell 2019;35:830–49. https://doi.org/10.1016/j.ccell.2019.04.002

  7. 7.

    Carbone M, Adusumilli PS, Richard Alexander Jr H, Baas P, Bardelli F, Bononi A, et al. Mesothelioma scientific clues fro prevention, diagnosis, and therapy. CA Cancer J Clin. 2019;69:402–29. https://doi.org/10.3322/caac.21572

  8. 8.

    Carbone M, Melino G. Steroyl CoA desaturase regulates ferroptosis in ovarian cancer offering new therapeutic perspectives. Cancer Res. 2019. In press.

  9. 9.

    Affar EB, Carbone M. BAP1 regulates different mechanisms of cell death. Cell Death Dis. 2018;9:1151. https://doi.org/10.1038/s41419-018-1206-5

  10. 10.

    Furth N, Aylon Y. The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway. Cell Death Differ. 2017;24:1488–501. https://doi.org/10.1038/cdd.2017.99

  11. 11.

    Levine AJ. Reviewing the future of the P53 field. Cell Death Differ. 2018;25:1–2. https://doi.org/10.1038/cdd.2017.181

  12. 12.

    Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520:57–62.

  13. 13.

    Aubrey BJ, Kelly GL, Janic A, Herold MJ, Strasser A. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death Differ. 2018;25:104–13. https://doi.org/10.1038/cdd.2017.169

  14. 14.

    Sullivan KD, Galbraith MD, Andrysik Z, Espinosa JM. Mechanisms of transcriptional regulation by p53. Cell Death Differ. 2018;25:133–43. https://doi.org/10.1038/cdd.2017.174

  15. 15.

    Carbone M, Amelio I, Affar EB, Brugarolas J, Cannon-Albright LA, Cantley LC, et al. Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine. Cell Death Differ. 2018;25:1885–904.

Download references

Funding

MC grants: National Institutes of Health/National Cancer Institute, the US Department of Defense, and the UH Foundation (“Pathogenesis of Malignant Mesothelioma”; Honeywell International Inc, Riviera United‐4‐a Cure, Maurice and Joanna Sullivan Family Foundation); has a patent pending application for BAP1, a patent issued for “Using Anti‐HMGB1 Monoclonal Antibody or other HMGB1 Antibodies as a Novel Mesothelioma Therapeutic Strategy,” and a patent issued for “HMGB1 As a Biomarker for Asbestos Exposure and Mesothelioma Early Detection”; and is a board‐certified pathologist who provides consultation for mesothelioma expertise and diagnosis, including paid medical‐legal consulting. GM grants: UK Medical Research Council, Associazione Italiana per la Ricerca contro il Cancro (AIRC) to GM IG#20473 (2018-2022), Ministry of Health & MAECI Italy-China Science and Technology Cooperation (#PGR00961), and Regione Lazio through Lazio Innova Progetto Gruppo di Ricerca n 85-2017-14986; consults and works for Springer Nature.

Author information

Correspondence to Michele Carbone or Gerry Melino.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Carbone, M., Melino, G. Lipid metabolism offers anticancer treatment by regulating ferroptosis. Cell Death Differ 26, 2516–2519 (2019) doi:10.1038/s41418-019-0418-2

Download citation